Most cited papers in Healthcare cost, quality, practices
What are the most cited papers in Healthcare cost, quality, practices?
The most cited paper in Healthcare cost, quality, practices is "The Cochrane Collaboration's tool for assessing risk of bias in randomised trials" (Julian P. T. Higgins, Doug G. Altman, Peter Christian Gøtzsche et al., 2011), with 34,881 citations. Next come "Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies" (10,774) and "Dissecting racial bias in an algorithm used to manage the health of populations" (7,007).
Showing 50 of 100 papers. Every paper with more than 956 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | The Cochrane Collaboration's tool for assessing risk of bias in randomised trials Julian P. T. Higgins, Doug G. Altman, Peter Christian Gøtzsche et al. · BMJ | 18 Oct 2011 | 34,881 |
| 2 | Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies Erik B von Elm, Douglas G. Altman, Matthias Egger et al. · BMJ | 18 Oct 2007 | 10,774 |
| 3 | Dissecting racial bias in an algorithm used to manage the health of populations Ziad Obermeyer, Brian W. Powers, Christine Vogeli et al. · Science | 24 Oct 2019 | 7,007 |
| 4 | EQ-SD: a measure of health status from the EuroQol Group Rosalind Rabin, Frank de Charro · Annals of Medicine | 2001 | 5,748 |
| 5 | Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration Karel G.M. Moons, Douglas G. Altman, Johannes B. Reitsma et al. · Annals of Internal Medicine | 5 Jan 2015 | 5,388 |
| 6 | Incidence of Adverse Events and Negligence in Hospitalized Patients Troyen A. Brennan, Lucian L. Leape, Nan M. Laird et al. · New England Journal of Medicine | 7 Feb 1991 | 4,679 |
| 7 | Performance of ChatGPT on USMLE: Potential for AI-assisted medical education using large language models Tiffany H. Kung, Morgan Cheatham, Arielle Medenilla et al. · PLOS Digital Health | 9 Feb 2023 | 3,867 |
| 8 | From Triple to Quadruple Aim: Care of the Patient Requires Care of the Provider Thomas Bodenheimer, Christine A. Sinsky · The Annals of Family Medicine | Nov 2014 | 3,594 |
| 9 | Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration Jan Paul Vandenbroucke, Erik von Elm, Douglas G. Altman et al. · Annals of Internal Medicine | 16 Oct 2007 | 3,586 |
| 10 | TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods Professor Gary S. Collins et al. · BMJ | 16 Apr 2024 | 3,581 |
| 11 | Segmented regression analysis of interrupted time series studies in medication use research Anita Katharina Wagner, Stephen B. Soumerai, Fucheng Zhang et al. · Journal of Clinical Pharmacy and Therapeutics | Aug 2002 | 3,344 |
| 12 | Systematic reviews: CRD's guidance for undertaking reviews in health care Evelina Tacconelli · The Lancet Infectious Diseases | 23 Mar 2010 | 3,291 |
| 13 | What is “quality of evidence” and why is it important to clinicians? Gordon Henry Guyatt, Andrew David Oxman, Regina Kunz et al. · BMJ | May 2008 | 3,290 |
| 14 | Fair Allocation of Scarce Medical Resources in the Time of Covid-19 Ezekiel Emanuel, Govind Persad, Ross E. G. Upshur et al. · New England Journal of Medicine | 23 Mar 2020 | 3,284 |
| 15 | GRADE guidelines: A new series of articles in the Journal of Clinical Epidemiology Gordon Henry Guyatt, Andrew David Oxman, Holger Jens Schünemann et al. · Journal of Clinical Epidemiology | 25 Dec 2010 | 3,224 |
| 16 | Aging with multimorbidity: A systematic review of the literature Alessandra Marengoni, Sara B. Angleman, René J. F. Melis et al. · Ageing Research Reviews | 13 Mar 2011 | 3,208 |
| 17 | Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses Gillian D Sanders, Peter J. Neumann, Anirban Basu et al. · JAMA | 13 Sep 2016 | 3,113 |
| 18 | Information bias in health research: definition, pitfalls, and adjustment methods Alaa Althubaiti · Journal of Multidisciplinary Healthcare | May 2016 | 3,110 |
| 19 | Clinical guidelines: Potential benefits, limitations, and harms of clinical guidelines Steven H. Woolf, Richard Grol, Anastasia F. Hutchinson et al. · BMJ | 20 Feb 1999 | 2,579 |
| 20 | External validity of randomised controlled trials: “To whom do the results of this trial apply?” Peter Malcolm Rothwell · The Lancet | 2005 | 2,574 |
| 21 | Recommendations of the Panel on Cost-Effectiveness in Health and Medicine Milton C. Weinstein · JAMA | 16 Oct 1996 | 2,481 |
| 22 | Markov Models in Medical Decision Making Frank A. Sonnenberg, J. Robert Beck · Medical Decision Making | Dec 1993 | 2,439 |
| 23 | Implicit bias in healthcare professionals: a systematic review Chloë FitzGerald, Samia Hurst · BMC Medical Ethics | Mar 2017 | 2,391 |
| 24 | Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold Peter J. Neumann, Joshua T. Cohen, Milton C. Weinstein · New England Journal of Medicine | 27 Aug 2014 | 2,286 |
| 25 | Foundations of Cost-Effectiveness Analysis for Health and Medical Practices Milton C. Weinstein, William B. Stason · New England Journal of Medicine | 31 Mar 1977 | 2,149 |
| 26 | The Values and Value of Patient-Centered Care Ronald M. Epstein, Richard Lewis Street · The Annals of Family Medicine | Mar 2011 | 1,980 |
| 27 | Error in medicine. L L Leape · PubMed | 21 Dec 1994 | 1,971 |
| 28 | Disseminating Innovations in Health Care Donald M. Berwick · JAMA | 15 Apr 2003 | 1,926 |
| 29 | Improving the reporting of pragmatic trials: an extension of the CONSORT statement Merrick Zwarenstein, Shaun P. Treweek, Joel Joseph Gagnier et al. · BMJ | 11 Nov 2008 | 1,860 |
| 30 | KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for the Evaluation and Management of CKD Lesley A. Inker, Brad C. Astor, Chester H. Fox et al. · American Journal of Kidney Diseases | 20 Mar 2014 | 1,858 |
| 31 | Guidelines for authors and peer reviewers of economic submissions to the BMJ Michael Drummond, Tom Jefferson · BMJ | 3 Aug 1996 | 1,839 |
| 32 | Implementing Machine Learning in Health Care — Addressing Ethical Challenges Danton S. Char, Nigam Haresh Shah, David Christopher Magnus · New England Journal of Medicine | 14 Mar 2018 | 1,828 |
| 33 | Going from evidence to recommendations Gordon Henry Guyatt, Andrew David Oxman, Regina Kunz et al. · BMJ | 8 May 2008 | 1,813 |
| 34 | Health as a Theoretical Concept Christopher Boorse · Philosophy of Science | Dec 1977 | 1,772 |
| 35 | Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement Don Husereau, Michael Drummond, Stavros Petrou et al. · BMJ | 25 Mar 2013 | 1,772 |
| 36 | Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement Gretchen A Stevens, Leontine Alkema, Robert E. Black et al. · The Lancet | 28 Jun 2016 | 1,765 |
| 37 | Hidden in Plain Sight — Reconsidering the Use of Race Correction in Clinical Algorithms Darshali A. Vyas, Leo G. Eisenstein, David Shumway Jones · New England Journal of Medicine | 17 Jun 2020 | 1,747 |
| 38 | Presentation adapting a clinical comorbidity index for use with ICD-9-CM administrative data: Differing perspectives Patrick S. Romano, Leslie Leon Roos, James G. Jollis · Journal of Clinical Epidemiology | Oct 1993 | 1,734 |
| 39 | PROBAST: A Tool to Assess Risk of Bias and Applicability of Prediction Model Studies: Explanation and Elaboration Karel G.M. Moons, Robert F. Wolff, Richard D Riley et al. · Annals of Internal Medicine | 31 Dec 2018 | 1,730 |
| 40 | Discrimination and Calibration of Clinical Prediction Models Ana Carolina Alba, Thomas Agoritsas, Michael W. Walsh et al. · JAMA | 10 Oct 2017 | 1,716 |
| 41 | Practical Clinical Trials Sean Tunis, Daniel B. Stryer, Carolyn M. Clancy · JAMA | 23 Sep 2003 | 1,716 |
| 42 | Sensitivity, Specificity, and Predictive Values: Foundations, Pliabilities, and Pitfalls in Research and Practice Robert Trevethan · Frontiers in Public Health | 19 Nov 2017 | 1,669 |
| 43 | Health Care Spending in the United States and Other High-Income Countries Irene Papanicolas, Liana Woskie, Ashish K. Jha · JAMA | 13 Mar 2018 | 1,650 |
| 44 | How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. Andreas Laupacis, David H Feeny, Allan S. Detsky et al. · PubMed | 15 Feb 1992 | 1,587 |
| 45 | A Framework for Public Health Action: The Health Impact Pyramid Thomas R. Frieden · American Journal of Public Health | 18 Feb 2010 | 1,541 |
| 46 | Sifting the evidence---what's wrong with significance tests? Another comment on the role of statistical methods Jonathan A C Sterne · BMJ | 27 Jan 2001 | 1,511 |
| 47 | Physicians and the Pharmaceutical Industry Ashley D. Wazana · JAMA | 19 Jan 2000 | 1,423 |
| 48 | Understanding and using sensitivity, specificity and predictive values Rajul S. Parikh, Annie Mathai, Shefali R. Parikh et al. · Indian Journal of Ophthalmology | 2008 | 1,415 |
| 49 | The Swedish cause of death register Hannah L. Brooke, Mats Talbäck, Jesper Hörnblad et al. · European Journal of Epidemiology | Sep 2017 | 1,404 |
| 50 | Designing and evaluating complex interventions to improve health care Neil C Campbell, Elizabeth M. Murray, Janet H Darbyshire et al. · BMJ | Mar 2007 | 1,384 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.